Corrections:

Sham S. Kakar^1,2, Seema Parte², Kelsey Carter¹, Irving G. Joshua¹, Christopher Worth², Pranela Rameshwar³ and Mariusz Z. Ratajczak⁴

¹ Department of Physiology, University of Louisville, Louisville, KY 40202, USA
² James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA
³ Department of Medicine, Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ 07103, USA
⁴ Department of Medicine, University of Louisville, Louisville, KY 40202, USA

Published: August 11, 2020

This article has been corrected: In Figure 3, panel F is an accidental duplicate of panel C. The corrected Figure 3 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:74494–74505. DOI: https://doi.org/10.18632/oncotarget.20170.

Figure 3: Effect of WFA and CIS both alone and in combination on spheroid formation. (A) - Control, (B) - WFA (0.5 μM), (C) - WFA (1.5 μM), (D) - CIS (20 μM), (E) - WFA (0.5 μM) + CIS (20 μM), and (F) - WFA (1.5 μM) + CIS (20 μM). i) Photomicrographs of spheroids under various treatment groups as described above. ii) Quantitative analysis of spheroids. Spheroids > 50 mm were counted. The number shown is average of spheroids counted in 6 different low power fields at 200X. Data shown is representative of three independent experiments. * represents p < 0.05.